Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $190,274 - $313,226
-1,880 Reduced 50.0%
1,880 $223,000
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $64,774 - $106,630
640 Added 20.51%
3,760 $446,000
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $341 - $461
-4 Reduced 0.13%
3,120 $332,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $58,388 - $87,721
840 Added 36.78%
3,124 $310,000
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $220,200 - $289,177
2,284 New
2,284 $235,000
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $155,545 - $289,111
-1,230 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $6,774 - $11,055
30 Added 2.5%
1,230 $312,000
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $155,892 - $281,976
1,200 New
1,200 $282,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.